Biblio

Found 147 results

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

S. Da Mesquita, Papadopoulos, Z., Dykstra, T., Brase, L., Farias, F. Geraldo, Wall, M., Jiang, H., Kodira, C. Dilip, de Lima, K. Alves, Herz, J., Louveau, A., Goldman, D. H., Salvador, A. Francesca, Onengut-Gumuscu, S., Farber, E., Dabhi, N., Kennedy, T., Milam, M. Grace, Baker, W., Smirnov, I., Rich, S. S., Benitez, B. A., Karch, C. M., Perrin, R. J., Farlow, M., Chhatwal, J. P., Holtzman, D. M., Cruchaga, C., Harari, O., and Kipnis, J., “Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy.”, Nature, vol. 593, no. 7858, pp. 255-260, 2021.

P. L. De Jager, Shulman, J. M., Chibnik, L. B., Keenan, B. T., Raj, T., Wilson, R. S., Yu, L., Leurgans, S. E., Tran, D., Aubin, C., Anderson, C. D., Biffi, A., Corneveaux, J. J., Huentelman, M. J., Rosand, J., Daly, M. J., Myers, A. J., Reiman, E. M., Bennett, D. A., and Evans, D. A., “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.

J. L. Del-Aguila, Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J. P., Fernández, M. Victoria, Ibañez, L., Bradley, J., Wang, F., Bergmann, K., Davenport, R., Morris, J. C., Holtzman, D. M., Perrin, R. J., Benitez, B. A., Dougherty, J., Cruchaga, C., and Harari, O., “A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.”, Alzheimers Res Ther, vol. 11, no. 1, p. 71, 2019.

J. L. Del-Aguila, Benitez, B. A., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J. P., Farias, F. H. G., Fernández, M. Victoria, Ibañez, L., Jiang, S., Perrin, R. J., Cairns, N. J., Morris, J. C., Harari, O., and Cruchaga, C., “TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.”, Mol Neurodegener, vol. 14, no. 1, p. 18, 2019.

M. Ann A. DeMichele-Sweet, Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernández, I., Moreno-Grau, S., Tarraga, L., Boada, M., Alarcón-Martín, E., Valero, S., Liu, Y., Hooli, B., Aarsland, D., Selbaek, G., Bergh, S., Rongve, A., Saltvedt, I., Skjellegrind, H. K., Engdahl, B., Stordal, E., Andreassen, O. A., Djurovic, S., Athanasiu, L., Seripa, D., Borroni, B., Albani, D., Forloni, G., Mecocci, P., Serretti, A., De Ronchi, D., Politis, A., Williams, J., Mayeux, R., Foroud, T., Ruiz, A., Ballard, C., Holmans, P., Lopez, O. L., M Kamboh, I., Devlin, B., and Sweet, R. A., “Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.”, Mol Psychiatry, 2021.

M. A. A. DeMichele-Sweet, Weamer, E. A., Klei, L., Vrana, D. T., Hollingshead, D. J., Seltman, H. J., Sims, R., Foroud, T., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Ruiz, A., Williams, J., Mayeux, R., Lopez, O. L., Sibille, E. L., Kamboh, M. I., Devlin, B., and Sweet, R. A., “Genetic risk for schizophrenia and psychosis in Alzheimer disease.”, Mol Psychiatry, vol. 23, no. 4, pp. 963-972, 2018.

Y. Deming, Xia, J., Cai, Y., Lord, J., Holmans, P., Bertelsen, S., Holtzman, D., Morris, J. C., Bales, K., Pickering, E. H., Kauwe, J., Goate, A., and Cruchaga, C., “A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.”, Neurobiol Aging, vol. 37, pp. 208.e1-208.e9, 2016.

Y. Deming, Filipello, F., Cignarella, F., Cantoni, C., Hsu, S., Mikesell, R., Li, Z., Del-Aguila, J. L., Dube, U., Farias, F. Geraldo, Bradley, J., Budde, J., Ibañez, L., Fernández, M. Victoria, Blennow, K., Zetterberg, H., Heslegrave, A., Johansson, P. M., Svensson, J., Nellgård, B., Lleó, A., Alcolea, D., Clarimón, J., Rami, L., Molinuevo, J. Luis, Suárez-Calvet, M., Morenas-Rodríguez, E., Kleinberger, G., Ewers, M., Harari, O., Haass, C., Brett, T. J., Benitez, B. A., Karch, C. M., Piccio, L., and Cruchaga, C., “The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.”, Sci Transl Med, vol. 11, no. 505, 2019.

Y. Deming, Li, Z., Kapoor, M., Harari, O., Del-Aguila, J. L., Black, K., Carrell, D., Cai, Y., Fernández, M. Victoria, Budde, J., Ma, S., Saef, B., Howells, B., Huang, K. - L., Bertelsen, S., Fagan, A. M., Holtzman, D. M., Morris, J. C., Kim, S., Saykin, A. J., De Jager, P. L., Albert, M., Moghekar, A., O'Brien, R., Riemenschneider, M., Petersen, R. C., Blennow, K., Zetterberg, H., Minthon, L., Van Deerlin, V. M., Lee, V. Man- Yee, Shaw, L. M., Trojanowski, J. Q., Schellenberg, G., Haines, J. L., Mayeux, R., Pericak-Vance, M. A., Farrer, L. A., Peskind, E. R., Li, G., Di Narzo, A. F., Kauwe, J. S. K., Goate, A. M., and Cruchaga, C., “Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.”, Acta Neuropathol, vol. 133, no. 5, pp. 839-856, 2017.

R. S. Desikan, Schork, A. J., Wang, Y., Witoelar, A., Sharma, M., McEvoy, L. K., Holland, D., Brewer, J. B., Chen, C. - H., Thompson, W. K., Harold, D., Williams, J., Owen, M. J., O'Donovan, M. C., Pericak-Vance, M. A., Mayeux, R., Haines, J. L., Farrer, L. A., Schellenberg, G. D., Heutink, P., Singleton, A. B., Brice, A., Wood, N. W., Hardy, J., Martinez, M., Choi, S. H., DeStefano, A., Ikram, M. A., Bis, J. C., Smith, A., Fitzpatrick, A. L., Launer, L., van Duijn, C., Seshadri, S., Ulstein, I. D., Aarsland, D., Fladby, T., Djurovic, S., Hyman, B. T., Snaedal, J., Stefansson, H., Stefansson, K., Gasser, T., Andreassen, O. A., and Dale, A. M., “Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.”, Mol Psychiatry, vol. 20, no. 12, pp. 1588-95, 2015.

R. S. Desikan, Fan, C. Chieh, Wang, Y., Schork, A. J., Cabral, H. J., L Cupples, A., Thompson, W. K., Besser, L., Kukull, W. A., Holland, D., Chen, C. - H., Brewer, J. B., Karow, D. S., Kauppi, K., Witoelar, A., Karch, C. M., Bonham, L. W., Yokoyama, J. S., Rosen, H. J., Miller, B. L., Dillon, W. P., Wilson, D. M., Hess, C. P., Pericak-Vance, M., Haines, J. L., Farrer, L. A., Mayeux, R., Hardy, J., Goate, A. M., Hyman, B. T., Schellenberg, G. D., McEvoy, L. K., Andreassen, O. A., and Dale, A. M., “Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.”, PLoS Med, vol. 14, no. 3, p. e1002258, 2017.

R. S. Desikan, Schork, A. J., Wang, Y., Thompson, W. K., Dehghan, A., Ridker, P. M., Chasman, D. I., McEvoy, L. K., Holland, D., Chen, C. - H., Karow, D. S., Brewer, J. B., Hess, C. P., Williams, J., Sims, R., O'Donovan, M. C., Choi, S. Hoan, Bis, J. C., M Ikram, A., Gudnason, V., DeStefano, A. L., van der Lee, S. J., Psaty, B. M., van Duijn, C. M., Launer, L., Seshadri, S., Pericak-Vance, M. A., Mayeux, R., Haines, J. L., Farrer, L. A., Hardy, J., Ulstein, I. Dina, Aarsland, D., Fladby, T., White, L. R., Sando, S. B., Rongve, A., Witoelar, A., Djurovic, S., Hyman, B. T., Snaedal, J., Steinberg, S., Stefansson, H., Stefansson, K., Schellenberg, G. D., Andreassen, O. A., and Dale, A. M., “Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.”, Circulation, vol. 131, no. 23, pp. 2061-2069, 2015.

M. T. W. Ebbert, Boehme, K. L., Wadsworth, M. E., Staley, L. A., Mukherjee, S., Crane, P. K., Ridge, P. G., and Kauwe, J. S. K., “Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.

P. M. Erlich, Lunetta, K. L., L Cupples, A., Huyck, M., Green, R. C., Baldwin, C. T., and Farrer, L. A., “Polymorphisms in the PON gene cluster are associated with Alzheimer disease.”, Hum Mol Genet, vol. 15, no. 1, pp. 77-85, 2006.

N. Ertekin-Taner, Ronald, J., Feuk, L., Prince, J., Tucker, M., Younkin, L., Hella, M., Jain, S., Hackett, A., Scanlin, L., Kelly, J., Kihiko-Ehman, M., Neltner, M., Hersh, L., Kindy, M., Markesbery, W., Hutton, M., de Andrade, M., Petersen, R. C., Graff-Radford, N., Estus, S., Brookes, A. J., and Younkin, S. G., “Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.”, Hum Mol Genet, vol. 14, no. 3, pp. 447-60, 2005.

M. Daniele Fallin, Szymanski, M., Wang, R., Gherman, A., Bassett, S. S., and Avramopoulos, D., “Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls.”, Neurogenetics, vol. 11, no. 3, pp. 335-48, 2010.

M. Victoria Fernández, Kim, J. Hun, Budde, J. P., Black, K., Medvedeva, A., Saef, B., Deming, Y., Del-Aguila, J., Ibañez, L., Dube, U., Harari, O., Norton, J., Chasse, R., Morris, J. C., Goate, A., and Cruchaga, C., “Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.”, PLoS Genet, vol. 13, no. 11, p. e1007045, 2017.

M. Victoria Fernández, Black, K., Carrell, D., Saef, B., Budde, J., Deming, Y., Howells, B., Del-Aguila, J. L., Ma, S., Bi, C., Norton, J., Chasse, R., Morris, J., Goate, A., and Cruchaga, C., “SORL1 variants across Alzheimer's disease European American cohorts.”, Eur J Hum Genet, vol. 24, no. 12, pp. 1828-1830, 2016.

S. Gao, Casey, A. E., Sargeant, T. J., and Mäkinen, V. - P., “Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.”, Brain, vol. 141, no. 9, pp. 2711-2720, 2018.

M. Ghani, Reitz, C., Cheng, R., Vardarajan, B. Narayan, Jun, G., Sato, C., Naj, A., Rajbhandary, R., San Wang, L. -, Valladares, O., Lin, C. - F., Larson, E. B., Graff-Radford, N. R., Evans, D., De Jager, P. L., Crane, P. K., Buxbaum, J. D., Murrell, J. R., Raj, T., Ertekin-Taner, N., Logue, M., Baldwin, C. T., Green, R. C., Barnes, L. L., Cantwell, L. B., M Fallin, D., Go, R. C. P., Griffith, P. A., Obisesan, T. O., Manly, J. J., Lunetta, K. L., M Kamboh, I., Lopez, O. L., Bennett, D. A., Hendrie, H., Hall, K. S., Goate, A. M., Byrd, G. S., Kukull, W. A., Foroud, T. M., Haines, J. L., Farrer, L. A., Pericak-Vance, M. A., Lee, J. H., Schellenberg, G. D., St George-Hyslop, P., Mayeux, R., and Rogaeva, E., “Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.”, JAMA Neurol, vol. 72, no. 11, pp. 1313-23, 2015.

R. K. Gopalraj, Zhu, H., Kelly, J. F., Mendiondo, M., Pulliam, J. F., Bennett, D. A., and Estus, S., “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.

R. C. Green, L Cupples, A., Go, R., Benke, K. S., Edeki, T., Griffith, P. A., Williams, M., Hipps, Y., Graff-Radford, N., Bachman, D., and Farrer, L. A., “Risk of dementia among white and African American relatives of patients with Alzheimer disease.”, JAMA, vol. 287, no. 3, pp. 329-36, 2002.

C. U. Greven, Bralten, J., Mennes, M., O'Dwyer, L., van Hulzen, K. J. E., Rommelse, N., Schweren, L. J. S., Hoekstra, P. J., Hartman, C. A., Heslenfeld, D., Oosterlaan, J., Faraone, S. V., Franke, B., Zwiers, M. P., Arias-Vasquez, A., and Buitelaar, J. K., “Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.”, JAMA Psychiatry, vol. 72, no. 5, pp. 490-9, 2015.

R. Guerreiro, Brás, J., Hardy, J., and Singleton, A., “Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.”, Hum Mol Genet, vol. 23, no. R1, pp. R47-53, 2014.

G. Han, Sun, J., Wang, J., Bai, Z., Song, F., and Lei, H., “Genomics in neurological disorders.”, Genomics Proteomics Bioinformatics, vol. 12, no. 4, pp. 156-63, 2014.